Launch week offerEnds in00h00m00s

annual Promonthly Pro

Christoph Ebner

Medical University of Innsbruck

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (14)

Collaborators (9)

Heidi Fiegl

Medical University of Innsbruck

Szabolcs Bozsa

University of Szeged

Christian Braun

Luzerner Kantonsspital

Teresa L. Pan

Medical University of Vienna

Jalid Sehouli

Charité - Universitätsmedizin Berlin

Toon Van Gorp

Universitaire Ziekenhuizen Leuven

Robin Ristl

Hubert Hackl

Associate Professor

Medical University of Innsbruck

Viola Heinzelmann-Schwarz

University Hospital Basel

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christoph Ebner

Research Interests

Make your next move.

Explore related searches

Articles (14)

Collaborators (9)

Heidi Fiegl

Szabolcs Bozsa

Christian Braun

Teresa L. Pan

Jalid Sehouli

Toon Van Gorp

Robin Ristl

Hubert Hackl

Viola Heinzelmann-Schwarz

Make your next move.

Christoph Ebner

Research Interests

Make your next move.

Explore related searches

Articles (14)

Early Normalization of Squamous Cell Carcinoma Antigen During Combined Chemoradiation Predicts Pathological Response and Survival in Squamous Cervical Cancer: A Retrospective Cohort Study

Patients’ Perception of Follow-Up Care and Personal Health Status of 677 Long-Term Survivors of Gynecological Cancer from the Study “Expression IX—Long-Term Survival with Gynecological Cancer”: The International NOGGO, ENGOT and GCIG Survey

Die Eliminationsgeschwindigkeit von squamous cell carcinoma antigen (SCC-A) unter kombinierter Radiochemotherapie beim Zervixkarzinom ist ein prognostischer Marker für das Überleben

Frühe Normalisierung von squamous cell carcinoma antigen (SCC-A) unter kombinierter Radiochemotherapie beim Zervixkarzinom kann histologsisches Ansprechen und Überleben vorhersagen

Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer

Biopsy‐proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome—Retrospective single‐center cohort study

Hirnmetastasen beim POLE mutierten Endometriumkarzinom – Eine Fallserie

The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of TP53-Mutated High-Grade Serous Ovarian Cancer

Are brain metastases a special issue in POLE-mutated endometrial cancer? a case report series

Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome

An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature

Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres

The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective

Collaborators (9)

Heidi Fiegl

Szabolcs Bozsa

Christian Braun

Teresa L. Pan

Jalid Sehouli

Toon Van Gorp

Robin Ristl

Hubert Hackl

Viola Heinzelmann-Schwarz

Make your next move.